Camille MacMillin/STAT

12 ideas for tackling the U.S. alcohol epidemic

Final installment of 'Deadliest Drug' series on the public health costs of alcohol. Knowing Prohibition was a failure, experts have a dozen other ideas.

By Isabella Cueto and Lev Facher

FDA authorized Zyn nicotine pouches without knowing what they were made of, says former agency scientist

Former FDA toxicologist says Zyn nicotine pouches were authorized without knowing what they're made of, raises concerns about microplastics.

By Matthew Chapman and Kathryn Kranhold — The Examination

As cyclospora illnesses surge to a record, Michigan officials eye lettuce as a possible cause

State-level data suggest U.S. cases now above the 2019 record of 4,700. Michigan officials focus on lettuce as possible cause, precise origin still unknown.

By Associated Press

STAT+ | 10 charts that explain America’s hidden alcohol epidemic

A deep dive into why America has a public health blind spot on alcohol: An all-charts look from the special STAT series "Deadliest Drug."

By J. Emory Parker, Lev Facher, and Isabella Cueto

STAT+ | Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study shows

The drug sowed decline by 26%, a result that, if confirmed in a Phase 3 study, could lead to a debate about the benefits for patients.

By Andrew Joseph

STAT+ | Top Democrats question RFK Jr.’s health care advisory panel

Democratic senators ask why Kennedy's panel includes Trump donors, many health care execs, and motivational speaker Tony Robbins.

By Chelsea Cirruzzo

Adobe

Opinion: It looks like your doctor and talks like your doctor. But it’s not your doctor

Deepfakes undermine the credibility that makes digital care possible.

By Henry Bair

STAT+ | Hospital chain HCA warns of lower profits as more patients go uninsured

An early indicator of the fallout from Congress ending extra ACA subsidies: HCA says treating uninsured patients will cut profits by $1.2 billion in 2026.

By Tara Bannow